全文获取类型
收费全文 | 126685篇 |
免费 | 9865篇 |
国内免费 | 3996篇 |
专业分类
耳鼻咽喉 | 215篇 |
儿科学 | 1542篇 |
妇产科学 | 382篇 |
基础医学 | 6264篇 |
口腔科学 | 666篇 |
临床医学 | 21412篇 |
内科学 | 36360篇 |
皮肤病学 | 403篇 |
神经病学 | 6821篇 |
特种医学 | 4924篇 |
外国民族医学 | 6篇 |
外科学 | 6532篇 |
综合类 | 24995篇 |
现状与发展 | 7篇 |
预防医学 | 8239篇 |
眼科学 | 579篇 |
药学 | 13300篇 |
208篇 | |
中国医学 | 6140篇 |
肿瘤学 | 1551篇 |
出版年
2024年 | 286篇 |
2023年 | 1824篇 |
2022年 | 3298篇 |
2021年 | 5093篇 |
2020年 | 5024篇 |
2019年 | 4099篇 |
2018年 | 4072篇 |
2017年 | 4267篇 |
2016年 | 4734篇 |
2015年 | 4714篇 |
2014年 | 9646篇 |
2013年 | 9500篇 |
2012年 | 8700篇 |
2011年 | 8974篇 |
2010年 | 7126篇 |
2009年 | 6394篇 |
2008年 | 6333篇 |
2007年 | 6425篇 |
2006年 | 5843篇 |
2005年 | 4967篇 |
2004年 | 3903篇 |
2003年 | 3416篇 |
2002年 | 2920篇 |
2001年 | 2721篇 |
2000年 | 2180篇 |
1999年 | 1875篇 |
1998年 | 1652篇 |
1997年 | 1554篇 |
1996年 | 1180篇 |
1995年 | 1065篇 |
1994年 | 944篇 |
1993年 | 794篇 |
1992年 | 668篇 |
1991年 | 600篇 |
1990年 | 485篇 |
1989年 | 430篇 |
1988年 | 419篇 |
1987年 | 369篇 |
1986年 | 313篇 |
1985年 | 384篇 |
1984年 | 295篇 |
1983年 | 181篇 |
1982年 | 217篇 |
1981年 | 180篇 |
1980年 | 127篇 |
1979年 | 93篇 |
1978年 | 76篇 |
1977年 | 63篇 |
1976年 | 40篇 |
1975年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
目的明确Angiomemor(美国Simbionix公司生产)血管介入仿真模拟器是否有助于冠状动脉造影技术的掌握和提高。方法选取16名无血管放射介入经验的心血管医生,接受相同课时的冠状动脉介入造影理论培训后,按随机表编码随机分为模拟器培训组与非培训组各8名,模拟器培训组8名医生接受Angiomemor血管介入仿真模拟器培训,模拟冠状动脉造影操作,非培训组8名心血管医生未接受仿真模拟器培训。在随后的真实临床环境中操作冠状动脉造影时,评价2组医生冠状动脉造影操作过程中错误的频数、平均造影时间、造影剂使用量及术中放射线剂量。结果相对于非培训组,模拟器培训组医生在冠状动脉造影操作中错误频数减少62.5%、平均造影时间减少44.0%、造影剂使用量减少44.0%,术中平均放射线曝光时间减少了57.7%,平均X线累计曝光剂量减少51.6%,单位面积X线累计曝光剂量减少了52.4%。结论Angiomemor血管介入仿真模拟器有助于医生较快地熟练掌握冠状动脉造影技术,是冠状动脉介入规范化培训的重要辅助手段之一。 相似文献
73.
Robert M. Levy Roman Saikovsky Evgeniya Shmidt Alexander Khokhlov Bruce P. Burnett 《Nutrition Research》2009
Flavocoxid (Limbrel), a proprietary mixture of flavonoid molecules (baicalin and catechin), was tested against a traditional nonsteroidal anti-inflammatory drug, naproxen, for the management of the signs and symptoms of moderate osteoarthritis (OA) in humans. Discomfort and global disease activity were used as the primary end points, and safety assessments were also taken for both treatments as a secondary endpoint. In this double-blind study, 103 subjects were randomly assigned to receive either flavocoxid [500 mg twice daily (BID)] or naproxen (500 mg BID) in a 1-month onset of action trial. Outcome measures included the short Western Ontario and McMaster University Osteoarthritis Index, subject Visual Analogue Scale for discomfort and global response, and investigator Visual Analogue Scale for global response and fecal occult blood. Both flavocoxid and naproxen showed significant reduction in the signs and symptoms of knee OA (P ≤ .001). There were no statistically detectable differences between the flavocoxid and naproxen groups with respect to any of the outcome variables. Similarly, there were no statistically detectable differences between the groups with respect to any adverse event, although there was a trend toward a higher incidence of edema and nonspecific musculoskeletal discomfort in the naproxen group. In this short-term pilot study, flavocoxid was as effective as naproxen in controlling the signs and symptoms of OA of the knee and would present a safe and effective option for those individuals on traditional nonsteroidal anti-inflammatory drugs or cyclooxygenase-2 inhibitors. A low incidence of adverse events was reported for both groups. 相似文献
74.
Amit Dang MBBS Gaurav Garg Padmanabh V. Rataboli MD 《The International journal of eating disorders》2009,42(4):385-386
Nocturnal Sleep‐Related Eating Disorder (NSRED) is a well‐documented sleeping disorder where the person is reported to experience bizarre eating behavior during sleep. Although various causes are implicated in this disorder, role of drugs cannot be ruled out. Here we narrate an interesting rare case report of a drug‐induced new onset NSRED, where a 45‐year‐old man on zolipdem performed an unexpected and bizarre eating behavior during somnambulistic state, type of which has not been reported earlier in the literature. The case falls under even rarer category as such behavior in sleep is reported mainly in woman. © 2008 by Wiley Periodicals, Inc. Int J Eat Disord 2009 相似文献
75.
目的研究原癌基因c-myc和jun在人胎冠状动脉发育过程中的表达与平滑肌细胞增殖的关系.方法用原位杂交方法检测,胎龄分别为16周、22周(因治疗需要引产)的胎儿和意外死亡的足月胎儿冠状动脉前降支c-myc mRNA和jun mRNA的表达水平.杂交反应产物用图像分析仪(MIAS300)作定量分析.结果C-myc mRNA原位杂交反应产物与被测血管区域面积的百分比在16周、22周和足月胎儿分别是70、56和10;Jun mRNA的杂交信反应产物与被测血管区域面积的百分比在这三个时期分别是68、53和8.两个原癌基因在不同阶段的表达均具有显著性差异.结论本实验首次报道c-myc和jun在人胎冠状动脉发育过程中平滑肌的表达图型,c-myc和jun在胎儿冠状动脉平滑肌细胞增殖和内膜的形成过程中可能具有重要的调控作用. 相似文献
76.
益气复智颗粒对多发脑梗死性痴呆模型大鼠脑组织细胞凋亡的影响 总被引:1,自引:0,他引:1
目的 观察益气复智颗粒对多发脑梗死性痴呆模型大鼠脑皮质形态学、细胞凋亡的影响。方法 采用颈内动脉注射血栓的方法,复制多发梗死性痴呆大鼠模型,观察益气复智颗粒12.42g/kg分别于手术前、手术前后、手术后灌胃对实验动物脑皮质形态学、细胞凋亡的影响。结果 益气复智颗粒能使脑缺血后脑内神经细胞凋亡数目下降。结论 益气复智颗粒具有较好的保护脑神经元,阻断脑缺血致神经细胞死亡病理过程的作用。 相似文献
77.
目的:探讨检测血清P-选择素水平与冠脉病变严重度的关系。方法:70冽冠D病患者,按临床诊断分为2组:急性冠脉综合症组32冽和稳定型冠心病组38例,对照组患者30例。ELISA检测各组患者血清中P-选择素水平.并比较各组间的差异;冠脉造影术对冠脉病变进行Gensini评分,并了解其与血清中P-选择素的相关性。结果:冠心病患者血清中的P-选择素水平显著高于正常对照组;在冠D病组内,急性冠脉综合症组的P-选择素水平显著高于稳定型冠心病患者,但两组冠脉病变Gemini评分无显著差别;而且冠脉病变Gemini评分与血清中P-选择素水平呈明显的相关性。结论:P-选择素可能参与了冠状动脉粥样硬化的发生和发展过程,血清P-选择素水平可能是冠脉病变严重度的一个预测指标。 相似文献
78.
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS 总被引:2,自引:0,他引:2
I. FUCHS† M. FROSSARD† A. SPIEL E. RIEDMÜLLER† A. N. LAGGNER† B. JILMA 《Journal of thrombosis and haemostasis》2006,4(12):2547-2552
BACKGROUND: Platelet hyperfunction contributes to acute coronary syndromes (ACS). Thus, we hypothesized that platelet function under high shear stress predicts recurrent ACS during long-term follow-up of ACS patients. PATIENTS AND METHODS: Consecutive ACS patients (n = 208) were prospectively followed-up for an average of 28 months. Platelet function was measured with the platelet function analyzer (PFA-100; Dade Behring, Marburg, Germany) at baseline for collagen/adenosine diphosphate closure times (CADP-CT) and for collagen/epinephrine closure times (CEPI-CT) after infusion of a uniform dose of 250 mg aspirin. RESULTS: Of the conventional risk factors, only the prevalence of diabetes was higher in ACS patients with re-events. However, use of clopidogrel and use of beta blockers were also slightly lower in patients with re-events (P < 0.05). The unadjusted risk hazard ratio (HR) for re-events was 3.3 [95% confidence interval (95% CI): 1.4-7.4; P = 0.005] in those patients with the shortest CADP-CT values (lowest quartile). Similarly, the risk was 2.0-fold higher (95% CI: 1.1-3.6; P = 0.02) in ACS patients with CEPI-CT < 300 s as compared with CEPI-CT >or = 300 s. Inclusion of diabetes, clopidogrel and beta blockers in a multivariate Cox regression model enhanced the predictive value of CEPI-CT (HR: 2.7). Inclusion of von Willebrand factor levels did not alter the HR for recurrent ACS (HR: 2.1; 95% CI: 1.1-5.2; P = 0.03) for CEPI-CT < 300 s, but reduced the HR for CADP-CT (HR: 2.8, 95% CI: 0.8-9.8; P = 0.11). CONCLUSION: Shortened CT values reflect biologically relevant platelet hyperfunction in patients with ACS because they predict recurrent ACS. 相似文献
79.
80.
黄震华 《中国新药与临床杂志》2005,24(10):829-832
心肌钠钙交换在调节心肌细胞内外钠、钙平衡中发挥重要作用。钠钙交换分为前向型和逆向型2种。在心力衰竭、心肌缺血、心肌再灌注等病理情况下,通过钠钙交换器的离子交换可产生致心律失常性的一过性内向电子流,引起延迟后除极和非折返激动型的室性心动过速。钠钙交换器抑制药在预防这些病理情况下的心律失常具有潜在的作用。 相似文献